Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention Intravacc’s recent research, featured in the peer-reviewed journal ‘Current Opinion in Immunology’ Volume 84 (2023), explores the potential of OMV-based vaccines in mucosal immunization. OMVs, derived from Gram-negative bacteria,…
Intravacc, located at Utrecht Science Park Bilthoven in the Netherlands, is a leading global contract development and manufacturing organization of innovative vaccines against infectious diseases. With over 100 years of experience in vaccine development and optimization, Intravacc has transferred its technology related to polio vaccines, measles vaccines, DPT vaccines, Hib vaccines and influenza vaccines around the world.
[modal_popup_box width=”430″ toppadding=”0″ leftpadding=”0″ btnsize=”50″ btnradius=”50″ titletext=”” contentpad=”0″ contentpad2=”0″ border=”0px solid #44448F !important” bodybg=”#161616″ btn_icon=”fas fa-play” btnclr=”#ffffff” btnbg=”#d0df00″ bgclr=”rgba(255,255,255,0.01)” titlebg=”rgba(255,255,255,0.01)”][/modal_popup_box]
Join our team!
Are you interested in becoming part of an innovative community, to learn alongside top scientists, to work with state-of-the art equipment, to get an inside look of and contribute to the biotech sector, where industry leaders, government, universities and international non-governmental organizations collaborate? Then Intravacc is the place for you.
Subscribe to our news update
Stay up to date with the latest developments, and be the first to receive our news updates and announcements.